<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="43701">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02112825</url>
  </required_header>
  <id_info>
    <org_study_id>1207M17821</org_study_id>
    <secondary_id>R03DK097318</secondary_id>
    <nct_id>NCT02112825</nct_id>
  </id_info>
  <brief_title>Exercise as an Adjunct Therapy to Reduce Blood Pressure in Chronic Kidney Disease</brief_title>
  <acronym>PACE</acronym>
  <official_title>Exercise as an Adjunct Therapy to Reduce Blood Pressure in Chronic Kidney Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Minnesota - Clinical and Translational Science Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Minnesota - Clinical and Translational Science Institute</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The general objective of the study is to investigate the effect of regular aerobic exercise
      on resting and 24-hr blood pressure levels in men and women with stage 3-4 kidney disease
      and hypertension.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Anticipated">June 2015</completion_date>
  <primary_completion_date type="Anticipated">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>blood pressure</measure>
    <time_frame>at week 0 and at week 12</time_frame>
    <safety_issue>No</safety_issue>
    <description>resting and 24-hour ambulatory blood pressure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>effective vascular compliance</measure>
    <time_frame>at week 0 and at week 12</time_frame>
    <safety_issue>No</safety_issue>
    <description>Pulse wave velocity estimated systemic vascular resistance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>endothelial function</measure>
    <time_frame>at week 0 and at week 12</time_frame>
    <safety_issue>No</safety_issue>
    <description>measured by brachial artery flow mediated vasodilation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>biomarkers associated with blood pressure</measure>
    <time_frame>at week 0 and at week 12</time_frame>
    <safety_issue>No</safety_issue>
    <description>Circulating levels of angiotensin 2 Circulating levels of endothelin 1 asymmetric dimethylarginine</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Focus Chronic Kidney Disease With Hypertension</condition>
  <arm_group>
    <arm_group_label>Exercise</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>12 weeks of blended supervised-home based exercise 3-4 times per week for 30-45 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Control group asked to continue usual activities</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Exercise</intervention_name>
    <description>Blended supervised-home based walking exercise 3-4 times per week for 30-45 minutes</description>
    <arm_group_label>Exercise</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  â€¢ Non-diabetic and &gt;18 years of age

               -  Diagnosed kidney disease with associated hypertension:

               -  Non-nephrotic range proteinuria at diagnosis

               -  No active glomerular disease or concomitant systemic inflammatory disease (e.g.
                  lupus)

               -  Systolic blood pressure &gt;130 and/or diastolic blood pressure &gt;80 mm Hg (on
                  medication)

               -  An estimated glomerular filtration rate of between 60 ml/min and 15 ml/min.

               -  Individuals must be able to provide informed consent

               -  Perform walking exercise training on a treadmill

               -  Be able to participate in a 12-week supervised exercise program.

        Exclusion Criteria:

          -  Currently participating in a formal exercise program

          -  Diabetes, active glomerular disease, or systemic inflammatory disease

          -  Requiring dialysis

          -  Have an Hematocrit &lt;27%

          -  Uncontrolled hypertension (&gt;200/110mmHg)

          -  Peripheral vascular disease.

          -  An inability to understand English or give consent. Other exclusion criteria are: any
             contraindications to exercise testing or training as indicated by the American
             College of Sports Medicine guidelines such as: Unstable coronary heart disease and
             symptomatic heart failure, exercise capacity limited by health problems such as
             angina, severe arthritis, or extreme dyspnea on exertion, progressive neuromuscular
             disease, pulmonary disease, or having undergone a coronary revascularization within
             the past 6 months prior to enrollment.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ulf G Bronas, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Minnesota - Clinical and Translational Science Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ulf G Bronas, PhD</last_name>
    <phone>612-625-9308</phone>
    <email>brona001@umn.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Minnesota</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ulf G Bronas, PhD</last_name>
      <phone>612-625-9308</phone>
      <email>brona001@umn.edu</email>
    </contact>
    <investigator>
      <last_name>Ulf G Bronas, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 10, 2014</lastchanged_date>
  <firstreceived_date>April 10, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Minnesota - Clinical and Translational Science Institute</investigator_affiliation>
    <investigator_full_name>Ulf G. Bronas</investigator_full_name>
    <investigator_title>Assistant professor</investigator_title>
  </responsible_party>
  <keyword>Exercise</keyword>
  <keyword>blood pressure</keyword>
  <keyword>chronic kidney disease</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
    <mesh_term>Kidney Failure, Chronic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
